Cost-effectiveness of biologics in early rheumatoid arthritis

Ann Intern Med. 2010 Mar 2;152(5):333-4; author reply 334. doi: 10.7326/0003-4819-152-5-201003020-00018.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antirheumatic Agents / economics*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Cost-Benefit Analysis
  • Humans
  • Immunologic Factors / economics*
  • Immunologic Factors / therapeutic use

Substances

  • Antirheumatic Agents
  • Immunologic Factors